1. Protein chip based miniaturized assay for the simultaneous quantitative monitoring of cancer biomarkers in tissue extracts
- Author
-
Michael Pawlak, Ulrike Weissenstein, Anneke Geurts-Moespot, Sabine Ehret, Urs Eppenberger, Michael J. Schneider, Peter Oroszlan, Fred C.G.J. Sweep, Serenella Eppenberger-Castori, and Jonas Cicenas
- Subjects
Vascular Endothelial Growth Factor A ,Analyte ,Statistics as Topic ,Protein Array Analysis ,Breast Neoplasms ,Aetiology, screening and detection [ONCOL 5] ,Biology ,Sensitivity and Specificity ,Biochemistry ,law.invention ,chemistry.chemical_compound ,Breast cancer ,Translational research [ONCOL 3] ,law ,Plasminogen Activator Inhibitor 1 ,Biomarkers, Tumor ,Image Processing, Computer-Assisted ,medicine ,Humans ,Molecular Biology ,Chemiluminescence ,Immunoassay ,Endocrinology and reproduction [UMCN 5.2] ,Tissue Extracts ,Hormonal regulation [IGMD 6] ,Reproducibility of Results ,Cancer ,medicine.disease ,Urokinase-Type Plasminogen Activator ,Molecular biology ,Vascular endothelial growth factor ,chemistry ,Protein microarray ,Female ,Cancer biomarkers ,Plasminogen activator - Abstract
Contains fulltext : 50113.pdf (Publisher’s version ) (Closed access) A multiplexed fluorescence immunoassay using a novel planar waveguide technology-based microarray system, ZeptoMARK (Zeptosens), was developed to detect simultaneously urokinase-type plasminogen activator (uPA), plasminogen activator inhibitor-1 (PAI-1), and vascular endothelial growth factor (VEGF) in extracts of breast cancer tissues. The three analytes assay was cross-validated with single-analyte ELISA/chemiluminescence immunosorbent assay tests, revealing good correlations and enhanced assay sensitivities (LODs) of 1 pg/mL for uPA, 33 pg/mL for PAI-1, and 1 pg/mL for VEGF. Values were well within the 80-120% limits for assay recovery and within the +/-20% limits for assay precision. The uPA, PAI-1, and VEGF results obtained from 50 breast cancer cytosols using the protein array system demonstrated that the microarray-based multiplexed assay is a sensitive and robust tool to be used for the simultaneous quantification of cancer markers in small breast cancer tissue samples (core biopsies). The miniaturized, multiplexed assay format has a potential to be used for the quantitative analysis of a larger set of validated markers with significance in disease management.
- Published
- 2006
- Full Text
- View/download PDF